Fel d 1 peptides: Effect on skin tests and cytokine synthesis in cat-allergic human subjects

International Immunology

Volumn 8, Issue 12, 1996, Pages 1937-1945

  Simons, F Estelle R ^a,b   Imada, Mie ^a   Li, Yan ^a   Watson, Wade T A ^a   HayGlass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

Cat allergy; Cytokines; Fel d 1; IFN ; IL 10; IL 4; Peptide immunotherapy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PEPTIDE;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANIMALS; ASTHMA; CATS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOTHERAPY; MALE; PEPTIDE FRAGMENTS; RHINITIS; SKIN TESTS;

EID: 0030444839     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.12.1937     Document Type: Article

References (36)

1. Hetzel, C., Hoyne, G. F. and Lamb, J. R. 1995. Peptide-mediated immunoregulation. Int. Arch. Allergy Immunol. 107:275.
2. Mor, F. and Cohen, I. R. 1995. Vaccines to prevent and treat autoimmune diseases. Int. Arch. Allergy Immunol. 108:345.
3. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. J. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
4. O'Hehir, R. E., Garman, R. D., Greenstein, J. L. and Lamb, J. R. 1991. The specificity and regulation of T-cell responsiveness to allergens. Annu. Rev. Immunol. 9:67.
5. Freidhoff, L. R., Meyers, D. A. and Marsh, D. G. 1984. A genetic-epidemiologic study of human immune responsiveness to allergens in an industrial population. II. The associations among skin sensitivity, total serum IgE, age, sex, and the reporting of allergies in a stratified random sample. J. Allergy Clin. Immunol. 73:490.
6. Kleine-Tebbe, J., Kleine-Tebbe, A., Jeep, S., Schou, C., Lowenstein, H. and Kunkel, G. 1993. Role of the major allergen (Fel d l) in patients sensitized to cat allergens. Int. Arch. Allergy Immunol. 100:256.
7. Wood, R. A., Eggleston, P. A., Lind, P., Ingemann, L., Schwartz, B., Graveson, S., Terry, D., Wheeler, B. and Adkinson, N. F., Jr. 1988. Antigenic analysis of household dust samples. Am. Rev. Respir. Dis. 137:358.
8. Enberg, R. N. 1993. Ubiquitous presence of cat allergen in cat-free buildings: probable dispersal from human clothing. Ann. Allergy 70:471.
9. Wood, R. A. and Eggleston, P. A. 1995. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am. J. Respir. Crit. Care Med. 151:315.
10. Ohman, J. L., Jr, Findlay, S. R. and Leitermann, K. M. 1984. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J. Allergy Clin. Immunol. 74:230.
11. Van Metre, T. E., Marsh, D. G., Adkinson, N. F., Jr, Kagey-Sobotka, A., Khattignavong, A., Norman, P. S. and Rosenberg, G. L. 1988. Immunotherapy for cat asthma. J. Allergy Clin. Immunol. 82:1055.
12. Rohatgi, N., Dunn, K. and Chai, H. 1988. Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy. J. Allergy Clin. Immunol. 82:389.
13. Bertelsen, A., Andersen, J. B., Christensen, J., Ingemenn, L., Kristensen, T. and Ostergaard, P. A. 1989. Immunotherapy in dog and cat extracts in children. Allergy 44:330.
14. Hedlin, G., Graff-Lonnevig, V., Heilborn, H., Lilja, G., Norrlind, K., Pegelow, K., Sundin, B. and Lowenstein, H. 1991. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J. Allergy Clin. Immunol. 87:955.
15. Counsell, C. M., Greenstein, J. L., Garman. R. D and Ohman, J. L. 1994. Cat Immunotherapy decreases T cell reactivity and skin test reactivity to Fel d 1, the major allergen of cat allergy. J. Allergy Clin. Immunol. 93:231.
16. Norman, P. S. 1993. Therapeutic potential of peptides in allergic disease. Ann. Allergy 71:330.
17. Keating, K. M., Segal, D. B., Craig, S. J., Nault, A. K., Semensi, V., Wasserman, A. S., Counsell, C. M. and Bond, J. F. 1995. Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d 1 recombinant chains. Mol. Immunol. 32:287.
18. Rogers, B. L., Bond, J, F., Craig, S. J., Nault, A, K., Segal, D. B., Morgenstern, J. P., Chen, M. S., Bizinkauskas, C. B., Counsell, C. M., Lussier, A. M., et al. 1994. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes. Mol. Immunol. 31:955.
19. van Neerven, R. J., van de Pol, M. M., van Milligen, F. J., Jansen, H. M., Aalberse, R. C. and Kapsenberg, M. L. 1994. Characterization of cat dander-specific T lymphocytes from atopic patients. J. Immunol. 152:4203.
20. Counsell, C. M., Bond, J. F., Ohman, J. L., Jr, Greenstein, J. L. and Carman, R. D. 1996. Definition of the human T cell epitopes of Fel d 1, the major allergen of the domestic cat. J. Allergy Clin. Immunol., in press.
21. Briner, T. J., Kuo, M.-C., Keating, K. M., Rogers, B. L. and Greenstein, J. L. (1993). Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc. Natl Acad. Sci. USA 90:7608.
22. Jenkins, M. K. and Schwartz, R. H. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
23. Hoyne, G. F., O'Hehir, R. E., Wraith, D. C., Thomas, W. R. and Lamb, J. R. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med 178:1783.
24. + T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335.
25. Norman, P. S., Ohman, J. L., Long, A. A., Creticos, P. S., Shaked, Z., Wood, R. A., Eggleston, P. A., Jones, N. H. and Nicodemus, C. F. 1994. Early clinical experience with T cell reactive peptides from cat allergen Fel d 1. J. Allergy Clin. Immunol. 93:231 (Abstract).
26. Norman, P. S., Ohman, J. L., Long, A. A., Creticos, P. S., Gefter, M. L., Shaked, Z., Wood, R. A., Eggleston, P. A., Lichtenstein, L. M., Jones, N. H. and Nicodemus, C. F. 1995. Follow on study of the first clinical trial with T cell defined peptides from cat allergen Fel d 1. J. Allergy Clin. Immunol. 95:259 (Abstract).
27. Creticos, P. S., Spector, S. L., Busse, W. W., Israel, E., Nicodemus, C. F., Jones, N. H., Olson, T., Gefter, M. L., Lichtenstein, L. M. and Norman, P. S. 1995. Evaluation of T cell epitope defined peptides from cat allergen by bronchial challenge. J. Allergy Clin. Immunol. 95:390 (Abstract).
28. Norman, P. S., Pasatiempo, A. M. G., Creticos, P. S., Nicodemus, C. F., Jones, N. H., Lichtenstein, L. M. and Gefter, M. L. 1996. Intravenous administration of a potential T cell tolerogenic peptide to cat sensitive patients. J. Allergy Clin. Immunol. 97:386 (Abstract).
29. Turkeltaub, P. C., Rastogi, S. C., Baer, H., Anderson, M. C. and Norman, P. S. 1982. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J. Allergy Clin. Immunol. 70:343.
30. Li, Y., Stefura, W. P., Simons, F. E. R., Jay, F. T. and HayGlass, K. T. 1994. Limiting dilution analysis of antigen stimulated IL-4 and IFN-γ production in human mononuclear cell populations. J. Immunol. Methods 175:169.
31. Imada, M., Simons, F. E. R., Jay, F. T. and HayGlass, K. T. 1995. Antigen mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int. Immunol. 7:229.
32. Imada, M., Simons, F. E. R., Jay, F. T. and HayGlass, K. T. 1995. Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunology 85:373.
33. Higgins, J. A., Lamb, J. R., Marsh, S. G., Tonks, S., Hayball, J. D., Rosen-Bronson, S., Bodmer, J. G. and O'Hehir, R. E. 1992. Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite). J. Allergy Clin. Immunol. 90:749.
34. Jarman, E. R., Hawrylowicz, C. M., Panagiotopolou, E., O'Hehir, R. E. and Lamb, J. R. 1994. Inhibition of human T-cell responses to house dust mite allergens by a T-cell receptor peptide. J. Allergy Clin. Immunol. 94:844.
35. Greenstein, J. L., Morgenstern, J. P., LaRaia, J., Counsell, C. M., Goodwin, W. H., Lussier, A., Creticos, P. S., Norman, P. S. and Carman, R. D. 1992. Ragweed immunotherapy decreases T cell reactivity to recombinant Amb a I. Int. J. Allergy Clin. Immunol. 89:322.
36. Nicodemus, C. F. 1996. Tolerogenic peptides. In Austen, K. F., Burakoff, S. J., Rosen, F. S. and Strom, T. B., eds, Therapeutic Immunology, p. 628. Blackwell Scientific Publications, London.